(Q46703142)

24 December 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Memantine enhances the inhibitory effects of naltrexone on ethanol consumption (English)

1 reference

24 December 2017

0 references

Alexander Kuzmin

1

1 reference

24 December 2017

Tove Stenback

series ordinal

2

1 reference

24 December 2017

Sture Liljequist

series ordinal

3

1 reference

24 December 2017

language of work or name

English

0 references

publication date

14 February 2008

1 reference

24 December 2017

European Journal of Pharmacology

published in

1 reference

24 December 2017

volume

584

1 reference

24 December 2017

issue

2-3

1 reference

24 December 2017

page(s)

352-356

1 reference

24 December 2017

From controlled drug intake to loss of control: the irreversible development of drug addiction in the rat.

cites work

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Effects of Naltrexone Alone and In Combination With Acamprosate on the Alcohol Deprivation Effect in Rats

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

The NMDA/glycine receptor antagonist, L-701,324, produces discriminative stimuli similar to those of ethanol.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Acute effects of memantine in combination with alcohol in moderate drinkers.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Oral ethanol self-administration in the rat: effect of naloxone.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Anticataleptic potencies of glutamate-antagonists

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Competitive NMDA receptor antagonist, CGP 40116, substitutes for the discriminative stimulus effects of ethanol.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Effects of naloxone on limited-access ethanol drinking in rats.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Cue-induced behavioural activation: a novel model of alcohol craving?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Evidence for alcohol anti-craving properties of memantine

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Ethanol and N -methyl- D -aspartate receptor complex interactions: a detailed drug discrimination study in the rat

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Naltrexone in the treatment of alcohol dependence

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.EJPHAR.2008.02.015

Identifiers

DOI

10.1016/J.EJPHAR.2008.02.015

1 reference

24 December 2017

1 reference

24 December 2017